Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients

Saved in:

Bibliographic Details
Published in:	Cancer cell Vol. 40; no. 4; pp. 335 - 337
Main Authors:	Canti, Lorenzo, Ariën, Kevin K., Desombere, Isabelle, Humblet-Baron, Stéphanie, Pannus, Pieter, Heyndrickx, Leo, Henry, Aurélie, Servais, Sophie, Willems, Evelyne, Ehx, Grégory, Goriely, Stanislas, Seidel, Laurence, Michiels, Johan, Willems, Betty, Goossens, Maria E., Beguin, Yves, Marchant, Arnaud, Baron, Frédéric
Format:	Journal Article Web Resource
Language:	English
Published:	United States Elsevier Inc 11-04-2022 Cell Press
Subjects:	Antibody Formation BNT162 Vaccine COVID-19 - prevention & control Hematology Human health sciences Humans Hématologie Immunologie & maladie infectieuse Immunology & infectious disease Letter SARS-CoV-2 Sciences de la santé humaine Vaccination
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Other Sources-1 ObjectType-Article-2 content type line 63 ObjectType-Correspondence-1 scopus-id:2-s2.0-85125497316 These authors contributed equally
ISSN:	1535-6108 1878-3686 1878-3686
DOI:	10.1016/j.ccell.2022.02.005